In a bid to promote the manufacture of pharmaceuticals in the country, the Indian Government has announced plans to set up a Rs 500-crore venture capital fund to provide cheaper loans to firms looking to establish or upgrade manufacturing facilities.
- Home
- 
                                Generics 
                                                                News- FDA approves generic teriparatide and levetiracetam
- US generics launch and approval for Dr Reddy’s and Lupin
- Five Chinese companies join UN’s MPP for Covid-19 medicines
- South Korean companies to make generic Bridion and COVID-19 drugs
 Research- Japan’s drug shortage crisis: challenges and policy solutions
- Saudi FDA drug approvals and GMP inspections: trend analysis
- Generic medications in the Lebanese community: understanding and public perception
- Community pharmacists’ understanding of generic and biosimilar drugs: Lebanon case study
 
- 
                                Biosimilars 
                                                                News- FDA approves six denosumab biosimilars
- EMA recommends approval for four biosimilars targeting three therapies
- FDA approves first interchangeable rapid-acting insulin biosimilar, Kirsty
- ANVISA approves ranibizumab and tocilizumab biosimilars
 
- MORE EDITORIAL SECTIONS
- Search
 
                    


 
            
    
    
                         
                             
            
    
    
                                                                 
            
    
    
                                                                 
            
    
    
                                                                 
            
    
    
                                                                 
            
    
    
                                                         
            
    
    
                                                         
            
    
    
                                                        
 
            
Post your comment